Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

LON/SN stock hub

LON/SN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/SNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.3B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/SN

In the news

Latest news · LON/SN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.4

P25 12.9P50 16.9P75 23.5

Trailing P/E20.5

P25 15.9P50 22.9P75 35.8

ROE11.8

P25 -54.2P50 2.1P75 13.7

ROIC8.7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/SN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

250

Groups with data

Currency

USD

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	16,988
Employees Change	-361%
Employees Change Percent	-2.08
Enterprise value	GBX 11.4B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Devices
Isin	GB0009223206
Last refreshed	2026-05-10
Market cap	GBX 9.3B
Price	GBX 1,093
Price currency	GBX
Rev Per Employee	269,593.36x
Sector	Healthcare
Sic	3842
Symbol	lon/SN
Website	https://www.smith-nephew.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.98%
EV Earnings	24.53x
EV/EBIT	15.49x
EV/EBITDA	10.24x
EV/FCF	18x
EV/Sales	2.49x
FCF yield	6.78%
Forward P/E	13.38x
P/B ratio	2.38x
P/E ratio	20.55x
P/S ratio	2.04x
PE Ratio10 Y	35.46x
PE Ratio3 Y	28.02x
PE Ratio5 Y	33.26x
PEG ratio	1.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.23%
EBITDA Margin	21.67%
FCF margin	13.82%
Gross margin	68.25%
Gross Profit	GBX 3.1B
Gross Profit Growth	0.26%
Gross Profit Growth Q	0.52%
Gross Profit Growth3 Y	1.94%
Gross Profit Growth5 Y	2.24%
Net Income	GBX 464.4M
Net Income Growth	51.7%
Net Income Growth Q	67.68%
Net Income Growth Quarters	5%
Net Income Growth Years	3%
Net Income Growth3 Y	27.02%
Net Income Growth5 Y	23.45%
Pretax Margin	12.64%
Profit Margin	10.14%
Profit Per Employee	GBX 27,335
Profitable Years	31
ROA	5.27
Roa5y	4.67
ROCE	9.9
ROE	11.84
Roe5y	7.7
ROIC	8.73
Roic5y	8.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.92%
Cagr15y	5.37%
Cagr1y	5.76%
Cagr20y	6.79%
Cagr3y	-2.23%
Cagr5y	-4.67%
Div CAGR10	3.54%
Div CAGR3	-2.2%
Div CAGR5	1.12%
EPS Growth	52.34
EPS Growth Q	70.36
EPS Growth Quarters	5
EPS Growth Years	3
EPS Growth3 Y	27.06
EPS Growth5 Y	23.45
FCF Growth	40.59%
FCF Growth Q	10.19%
FCF Growth3 Y	41.46%
FCF Growth5 Y	107.78%
OCF Growth	30.19%
OCF Growth Q	18.69%
OCF Growth10 Y	3.23%
OCF Growth3 Y	20.58%
OCF Growth5 Y	28%
Revenue Growth	6.09x
Revenue Growth Q	7.38x
Revenue Growth Quarters	10x
Revenue Growth Years	5x
Revenue Growth3 Y	2.99x
Revenue Growth5 Y	2.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.59
Assets	GBX 7.8B
Cash	GBX 413.9M
Current Assets	GBX 3B
Current Liabilities	GBX 1.2B
Debt	GBX 2.5B
Debt EBITDA	GBX 2.4
Debt Equity	GBX 0.63
Debt FCF	GBX 3.9
Equity	GBX 3.9B
Interest Coverage	6.26
Liabilities	GBX 3.8B
Long Term Assets	GBX 4.8B
Long Term Liabilities	GBX 2.7B
Net Cash	GBX -2.1B
Net Cash By Market Cap	GBX -22.05
Net Debt EBITDA	GBX 2.07
Net Debt Equity	GBX 0.52
Net Debt FCF	GBX 3.25
Tangible Book Value	GBX 965.2M
Tangible Book Value Per Share	GBX 1.14
WACC	6.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.57
Inventory Turnover	0.87
Net Working Capital	GBX 1.6B
Quick ratio	1.17
Working Capital	GBX 1.9B
Working Capital Turnover	GBX 1.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	2.42%
Dividend Growth Years	0%
Dividend per share	GBX 0.29
Dividend Years	50
Dividend Yield	2.63%
Ex Div Date	2026-03-26
Last Dividend	GBX 0.18
Payout Frequency	Semi-Annual
Payout Ratio	52.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	20.89%
1Y total return	5.76%
200-day SMA	1,279.7
3Y total return	-6.54%
50-day SMA	1,225.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-21.25%
All Time High	2,023
All Time High Change	-45.97%
All Time High Date	2020-02-20
All Time Low	19.52
All Time Low Change	5,498.52%
All Time Low Date	1980-05-23
ATR	29.32
Beta	0.67
Beta1y	1.11
Beta2y	0.73
Ch YTD	-11.75
High	1,117
High52	1,441.5
High52 Date	2025-09-10
High52ch	-24.18%
Low	1,085.5
Low52	1,051.5
Low52 Date	2025-05-23
Low52ch	3.95%
Ma50ch	-10.82%
Price vs 200-day SMA	-14.59%
RSI	29.93
RSI Monthly	45.71
RSI Weekly	35.77
Sharpe ratio	0.16x
Sortino ratio	0.45
Total Return	2.97%
Tr YTD	-10.41
Tr15y	119.19%
Tr1m	-8.38%
Tr1w	-4.71%
Tr3m	-12.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 651.6M
Operating Income Growth	-11.14
Operating Income Growth Q	-19.71
Operating Income Growth3 Y	3.37
Operating Income Growth5 Y	5.04
Operating margin	14.23

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	844,133,081%
Net Borrowing	-99,757,904
Shares Insiders	0.13%
Shares Institutions	89.85%
Shares Out	853,971,798
Shares Qo Q	-1.56%
Shares Yo Y	-0.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX 601.1M
Average Volume	2,711,000x
Bv Per Share	4.62
CAPEX	GBX -321.7M
Ch10y	-3.79
Ch15y	58.18
Ch1m	-8.38
Ch1w	-4.71
Ch1y	3.31
Ch20y	151.3
Ch3m	-13.73
Ch3y	-13.67
Ch5y	-30.95
Ch6m	-13.7
Change	-1.89%
Change From Open	-1.62
Close	1,114
Days Gap	-0.27
Depreciation Amortization	336,682,926
Dollar Volume	2,531,631,739
Earnings Date	2026-08-04
EBIT	GBX 651.6M
EBITDA	GBX 992.6M
EPS	GBX 0.53
F Score	6
FCF	GBX 633M
FCF EV Yield	5.56x
FCF Per Share	GBX 0.74
Financing CF	-709,565,000
Fiscal Year End	December
Founded	1,856
Goodwill	2,279,761,512
Graham Number	750.349
Graham Upside	-31.35
Income Tax	GBX 114.4M
Investing CF	-301,658,000
Is Primary Listing	1
Last Earnings Date	2026-03-02
Last Report Date	2025-12-31
Last Split Date	2000-08-07
Last Split Type	Reverse
Lynch Fair Value	GBX 1,275
Lynch Upside	16.66
Ma150	1,261
Ma150ch	-13.32%
Ma20	1,190.7
Ma20ch	-8.21%
Net CF	-47,552,000
Next Earnings Date	2026-08-04
Open	1,111
P FCF Ratio	14.74
P OCF Ratio	9.78
Payment Date	2026-05-27
Position In Range	23.81
Ppne	1,201,495,932
Price Date	2026-05-08
Price EBITDA	GBX 9.4
Ptbv Ratio	9.67
Relative Volume	0.89x
Revenue	4,579,852,000x
SBC By Revenue	0.7x
Share Based Comp	31,949,000
Tax By Revenue	2.5x
Tax Rate	19.77%
Tr20y	272.17%
Tr6m	-12.39%
Volume	2,316,223
Z Score	3.42

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/SN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.6%

$0.29 annual per share

Payout ratio

+52.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+1.1%

0 consecutive years of growth

Total shareholder yield

+3.0%

Next ex-dividend date: 2026-03-26

Performance

LON/SN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/SN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+89.9%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.3%

Negative means the company is buying back shares.

Technical

LON/SN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

29.9

Below 30: short-term oversold

Price vs 200-day MA

-14.6%

50/200-day relationship not available

Beta (5Y)

0.67

Less volatile than the market

Sharpe ratio

0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/SN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/SN stock rating?

lon/SN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/SN analysis?

The full report lives at /stocks/lon/SN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/SN?

The latest report frames lon/SN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/SN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.